tbuckley/cabot-search huggingface dataset:
Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates
Authors: Tiancheng Liu, Jessica Hsiung, Su Zhao, Jessica Kost, Deepika Sreedhar, Carl V. Hanson, Kjerstie Olson, Douglas Keare, Shin Ting Chang, Kevin P. Bliden, Paul A. Gurbel, Udaya S. Tantry, John Roche, Cynthia Press, John Boggs, Jorge P. Rodriguez-Soto, Jose G. Montoya, Meijie Tang, Hongjie Dai
Journal: Nature Biomedical Engineering (2020)

Accurate assays for the detection of antibodies to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) are essential for the control of the COVID-19 (coronavirus disease 2019) pandemic. Here, we report antibody and antibody-avidity assays, relying on near-infrared-fluorescence amplification by nanostructured plasmonic gold substrates, for the simultaneous detection of antibodies to the S1 subunit of the spike protein and to the receptor binding domain of SARS-CoV-2 in human serum and saliva, and for quantifying immunoglobulin avidities against coronavirus antigens from SARS-CoV-2, SARS-CoV-1 and the common-cold viruses OC43, HKU1, NL63 and 229E. The antibody assay detected immunoglobulin M in 87% (52 of 60) COVID-19-positive serum samples collected 6 or more days after symptom onset (and the immunoglobulins M and G in all 33 samples collected at least 15 days after symptom onset), and correctly classified 456 out of the 457 COVID-19-negative serum samples tested (424 of them collected before the pandemic, including 73 that were positive for other viruses). We used the antibody-avidity assay to study antibody-maturation patterns, anamnestic responses, and cross-immunity to the common-cold coronaviruses. Antibody and antibody-avidity assays relying on near-infrared-fluorescence amplification by nanostructured plasmonic gold substrates accurately quantify antibodies to SARS-CoV-2 and to common viruses in human serum and saliva.
The Asia-Pacific Myeloma and Related Diseases Registry: Preliminary Results of Real-World Treatment Patterns and Clinical Outcomes
Authors: Kim Huynh, Naomi Aoki, Kihyun Kim, Wee Joo Chng, Gin Gin Gan, Chang-Ki Min, Je-Jung Lee, Yeow Tee Goh, Cameron Wellard, Zoe McQuilten, Elizabeth M. Moore, Erica M. Wood, Andrew Spencer
Journal: Blood (2020)
Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients
Authors: Teresa Aydillo, Alba Escalera, Shirin Strohmeier, Sadaf Aslam, Javier Sanchez-Cespedes, Juan Ayllon, Cristina Roca-Oporto, Pilar Perez-Romero, Miguel Montejo, Joan Gavalda, Patricia Munoz, Francisco Lopez-Medrano, Jordi Carratala, Florian Krammer, Adolfo García-Sastre, Elisa Cordero
Journal: Cell Reports Medicine (2020)

Hemagglutination-inhibitory antibodies are usually highly strain specific with little effect on infection with drifted or shifted strains. The significance of broadly cross-reactive non-HAI anti-influenza antibodies against conserved domains of virus glycoproteins, such as the hemagglutinin (HA) stalk, is of great interest. We characterize a cohort of 40 H1N1pmd09 influenza-infected patients and identify lower respiratory symptoms (LRSs) as a predictor for development of pneumonia. A binomial logistic regression of log10 pre-existing antibody values shows that the probability of LRS occurrence decreased with increased anti-HA full-length and stalk antibody ELISA titers. However, a multilevel logistic regression model adjusted by other potential serocorrelates demonstrates that only antibodies directed against the stalk of HA correlate with protection from lower respiratory infection, limiting disease progression. Our predictive model indicates that a threshold of protective immunity based on broadly cross-reactive HA stalk antibodies could be feasible.
Emerging Role of Adoptive T Cell Therapy for EBV Induced Nasopharyngeal Carcinoma (NPC) - a Systematic Review
Authors: Muhammad Saad Farooqi, Unaiza Faizan, Saad Ur Rahman, Hassaan Imtiaz, Muhammed Hamza Arshad, Arafat Ali Farooqui, Zahoor Ahmed, Muhammad Ali Aziz, Ali Jaan, Ali Shahbaz Baloch, Naurez Qasim, Arshia Akbar, Faiz Anwer
Journal: Blood (2020)
Left Ventricular End-Systolic Volume in Chronic Aortic Regurgitation—Finally, a Step Forward
Authors: Robert O. Bonow, Patrick T. O’Gara
Journal: JAMA Cardiology (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Cardiology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Cardiology journal
First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study
Authors: Ofir Wolach, Itai Levi, Jonathan Canaani, Tamar Tadmor, Sigal Tavor, Ilana Hellmann, Tsila Zuckerman, David Lavie, Galia Stemer, Raanan Cohen, Ran Afik, Keren Ofek, Hilla Banayan, Inna Kan, Moshe Grunspan, Yishai Ofran, Yakir Moshe
Journal: Blood (2020)
Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT
Authors: Devaki Shilpa Sudha Surasi, Yang Lu, Paul Corn, Curtis Pettaway, Tharakeswara Bathala
Journal: Clinical Nuclear Medicine (2020)

Abstract 18 F-Fluciclovine PET/CT has become a common diagnostic imaging study used in the evaluation of biochemical recurrence in prostate cancer since its approval in 2016. We present a case report of an 82-year-old man with history of both prostate and bladder cancer who presented for a fluciclovine study due to rising PSA levels. There was incidental detection of focal penile activity, and a subsequent urethral biopsy performed showed urothelial carcinoma, which was also seen on a subsequent MRI study.
Asymptomatic health-care worker screening during the COVID-19 pandemic – Authors' reply
Authors: Thomas A Treibel, Charlotte Manisty, Mervyn Andiapen, Corinna Pade, Melanie Jensen, Marianna Fontana, Xosé Couto-Parada, Teresa Cutino-Moguel, Mahdad Noursadeghi, James C Moon
Journal: The Lancet (2020)
28-Day Metronomic Therapy for Relapsed Refractory Multiple Myeloma
Authors: Tarek H Mouhieddine, Julia Hieulle, Erin Moshier, Josh R. Richter, Hearn Jay Cho, Samir Parekh, Ajai Chari, Bart Barlogie, Sundar Jagannath, Deepu Madduri
Journal: Blood (2020)
Role of the vascular endothelial sodium channel activation in the genesis of pathologically increased cardiovascular stiffness
Authors: Michael A Hill, Frederic Jaisser, James R Sowers
Journal: Cardiovascular Research (2020)

Cardiovascular (CV) stiffening represents a complex series of events evolving from pathological changes in individual cells of the vasculature and heart which leads to overt tissue fibrosis. While vascular stiffening occurs naturally with ageing it is accelerated in states of insulin (INS) resistance, such as obesity and type 2 diabetes. CV stiffening is clinically manifested as increased arterial pulse wave velocity and myocardial fibrosis-induced diastolic dysfunction. A key question that remains is how are these events mechanistically linked. In this regard, heightened activation of vascular mineralocorticoid receptors (MR) and hyperinsulinaemia occur in obesity and INS resistance states. Further, a downstream mediator of MR and INS receptor activation, the endothelial cell Na+ channel (EnNaC), has recently been identified as a key molecular determinant of endothelial dysfunction and CV fibrosis and stiffening. Increased activity of the EnNaC results in a number of negative consequences including stiffening of the cortical actin cytoskeleton in endothelial cells, impaired endothelial NO release, increased oxidative stress-meditated NO destruction, increased vascular permeability, and stimulation of an inflammatory environment. Such endothelial alterations impact vascular function and stiffening through regulation of vascular tone and stimulation of tissue remodelling including fibrosis. In the case of the heart, obesity and INS resistance are associated with coronary vascular endothelial stiffening and associated reductions in bioavailable NO leading to heart failure with preserved systolic function (HFpEF). After a brief discussion on mechanisms leading to vascular stiffness per se, this review then focuses on recent findings regarding the role of INS and aldosterone to enhance EnNaC activity and associated CV stiffness in obesity/INS resistance states. Finally, we discuss how coronary artery-mediated EnNaC activation may lead to cardiac fibrosis and HFpEF, a condition that is especially pronounced in obese and diabetic females.
Response to the EZH2 Inhibitor Tazemetostat Is Independent of Cell of Origin Determined Via Hans Imunohistochemistry or Nanostring Lymphoma Subtyping Test in EZH2 Wild-Type DLBCL Patients
Authors: Alice A. McDonald, Franck Morschhauser, Vincent Ribrag, Pamela McKay, Gilles Salles, Herve Tilly, Anna Schmitt, John Gerecitano, Michael J. Dickinson, Sarit Assouline, Corinne Haioun, John G. Gribben, Pier Luigi Zinzani, Helen Wu, Steven Kussick, James Storhoff, John Larus, Alicia Clawson, Adlai Grayson, Scott Daigle, Peter Ho, Harry Miao, Stephen Blakemore
Journal: Blood (2017)
Assembly of whole-chromosome pseudomolecules for polyploid plant genomes using outbred mapping populations
Authors: Chenxi Zhou, Bode Olukolu, Dorcus C. Gemenet, Shan Wu, Wolfgang Gruneberg, Minh Duc Cao, Zhangjun Fei, Zhao-Bang Zeng, Andrew W. George, Awais Khan, G. Craig Yencho, Lachlan J. M. Coin
Journal: Nature Genetics (2020)
Abstract PO-076: Training and information during COVID-19 pandemic: The masterpiece in young oncologists
Authors: Nicoletta Ranallo, Lucia Bastianelli, Filippo Merloni, Luca Cantini, Giulia Ricci, Zelmira Ballatore, Rossana Berardi
Journal: Clinical Cancer Research (2020)

Abstract Background: The COVID-19 pandemic was a health emergency that required a rapid response by the Italian National Health System. Health care professionals needed to be properly trained and informed about their patients' procedures and proper management. During an emergency, the information must be exhaustive, clear, and timely to allow correct diagnostic and therapeutic continuity. It is also important that all health workers are promptly and homogeneously trained to guarantee the best treatment path even during the pandemic. Our survey aimed to investigate the level of information and training of health workers in oncology during the pandemic and, in particular, the difference in perception between operators under and over 35 years of age. Materials and Methods: An on-line multiple-choice survey was submitted to oncology health workers during the pandemic, investigating individual perception of resources, information, and staff training management by hospital centers. No open questions were included. Results: A total of 383 health workers replied to the survey (116 under 35 years versus 267 over 35 years). In the under-35 group, a total of 65% declared they had been timely and sufficiently informed to understand the extent of the problem compared to 50% of those over 35 (P=0.007). About 80% of young professionals were adequately informed and two thirds (63%) were informed about procedures/recommendations to be followed during the pandemic. However, in professionals over 35, only 56% declared they had the right information and over 65% did not feel adequately trained (P= &amp;lt;0.01). Furthermore, 44% of those over 35 felt not sufficiently prepared for the management of the cancer patient during an epidemic compared to only 28% of those under 35 (P=0.015). Conclusion: The survey showed a different perception of information and training of health care professionals based on the age group. This could be determined by a different degree of task and responsibility but also by the greater and faster readiness of the younger operators to acquire new information and to draw on a renewed ability to face an emergency by reorganizing themselves quickly and actively. Citation Format: Nicoletta Ranallo, Lucia Bastianelli, Filippo Merloni, Luca Cantini, Giulia Ricci, Zelmira Ballatore, Rossana Berardi. Training and information during COVID-19 pandemic: The masterpiece in young oncologists [abstract]. In: Proceedings of the AACR Virtual Meeting: COVID-19 and Cancer; 2020 Jul 20-22. Philadelphia (PA): AACR; Clin Cancer Res 2020;26(18_Suppl):Abstract nr PO-076.
<i>In Vivo</i> Pre-Clinical Evaluation of LOXO-305 Alone and in Combination with Venetoclax, Rituximab, R-CHOP or Obinutuzumab on Human Xenograft Lymphoma Tumor Models in Mice
Authors: Eliana B. Gomez, Wenjuan Wu, Jennifer R Stephens, Mary S. Rosendahl, Barbara J. Brandhuber
Journal: Blood (2020)
Outcomes of <i>TP53</i>-Mutant Acute Myeloid Leukemia with Venetoclax and Decitabine
Authors: Kunhwa Kim, Abhishek Maiti, Tapan M. Kadia, Farhad Ravandi, Naval Daver, Naveen Pemmaraju, Gautam Borthakur, Prithviraj Bose, Ghayas C. Issa, Nicholas J. Short, Musa Yilmaz, Yesid Alvarado, Alessandra Ferrajoli, Elias Jabbour, Nitin Jain, Maro Ohanian, Koichi Takahashi, Philip A. Thompson, Caitlin R. Rausch, Kathryn Montalbano, Sherry A. Pierce, Keyur P. Patel, Guillermo Garcia-Manero, Hagop M. Kantarjian, Courtney D. DiNardo, Marina Konopleva
Journal: Blood (2020)
Cost and Healthcare Utilization in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Analysis of Medicare Beneficiaries Receiving Chimeric Antigen Receptor T-Cell Vs. Autologous and Allogeneic Hematopoietic Cell Transplants
Authors: Iman Mohammadi, Anna G Purdum, Anny C Wong, Amy Schroeder, Karl M Kilgore, Gunjan L. Shah
Journal: Blood (2020)
The Metabolomic Status of the Differentiating Myeloid Lineage in MDS with Low and High Bone Marrow Blast Counts
Authors: Aikaterini Poulaki, Theodora Katsila, Ioanna E Stergiou, Stavroula Giannouli, Jose Carlos Gόmez Tamayo, Konstantinos Kambas, George Patrinos, George Vassilopoulos, Michael Voulgarelis
Journal: Blood (2020)
Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans
Authors: Franziska M. Uhl, Sophia Chen, David O’Sullivan, Joy Edwards-Hicks, Gesa Richter, Eileen Haring, Geoffroy Andrieux, Sebastian Halbach, Petya Apostolova, Jörg Büscher, Sandra Duquesne, Wolfgang Melchinger, Barbara Sauer, Khalid Shoumariyeh, Annette Schmitt-Graeff, Marina Kreutz, Michael Lübbert, Justus Duyster, Tilman Brummer, Melanie Boerries, Tobias Madl, Bruce R. Blazar, Olaf Groß, Erika L. Pearce, Robert Zeiser
Journal: Science Translational Medicine (2020)

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (allo-HCT) has a dismal prognosis. We found that T cells of patients relapsing with AML after allo-HCT exhibited reduced glycolysis and interferon-γ production. Functional studies in multiple mouse models of leukemia showed that leukemia-derived lactic acid (LA) interfered with T cell glycolysis and proliferation. Mechanistically, LA reduced intracellular pH in T cells, led to lower transcription of glycolysis-related enzymes, and decreased activity of essential metabolic pathways. Metabolic reprogramming by sodium bicarbonate (NaBi) reversed the LA-induced low intracellular pH, restored metabolite concentrations, led to incorporation of LA into the tricarboxylic acid cycle as an additional energy source, and enhanced graft-versus-leukemia activity of murine and human T cells. NaBi treatment of post-allo-HCT patients with relapsed AML improved metabolic fitness and interferon-γ production in T cells. Overall, we show that metabolic reprogramming of donor T cells is a pharmacological strategy for patients with relapsed AML after allo-HCT.
Abstract 549: Characterization of Mesenchymal Stromal Cell-derived Exosomes From Patients With Improved Function Outcome After Ischemic Cardiomyopathy: A Biorepository Evaluation of the Focus-CCTRN Trial
Authors: Lourdes I Chacon, Fernanda Mesquita, Hassan Virk, Camila Hochman-mendez, Doris A Taylor
Journal: Circulation Research (2020)

Mesenchymal stromal cells derived from bone marrow (BM-MSCs) have been considered promisingcandidates for regenerative medicine therapies for more than 20 years, but to date cardiovascular clinicaltrials of MSC-based therapies have demonstrated only modest improvement. However, the mechanismsunderlying why some patients improve and others do not remain undefined. Although MSC survival aftertransplantation remains a challenge, several studies have reported that BM-MSC-mediated paracrineeffects and delivery of exosomes may be therapeutically relevant. We hypothesized that MSC-derivedexosomes from patients with cardiac functional improvement contain factors that promote cell survival,proliferation, and cardiac protection. Here, we compared exosomes (derived from MSCs that had beenexpanded from BM-MNCs used for autologous transplantation) from two cohorts of disease- and age-matched consented patients with ischemic cardiomyopathy enrolled in the FOCUS-CCTRN trial—thosewith improved (cohort1, n=3) or worsened (cohort2, n=3) functional outcome in three primary endpoints:left ventricular (LV) ejection fraction, LV end-systolic volume, and maximal oxygen consumption.MicroRNA-seq analysis identified 16 upregulated and 12 downregulated miRNAs in cohort 1 whencompared to cohort 2. Using DIANA-Mir Path v.3.0, we identified 3,522 experimentally validated genetargets. Gene set enrichment analysis identified enrichment for fatty acid biosynthesis and metabolism,Hippo signaling pathway, protein processing in endoplasmic reticulum, adherent junction, cell cycle,endocytosis, RNA transport and degradation, estrogen-signaling pathway, regulation of actincytoskeleton, Prolactin signaling pathway, Focal adhesion, Notch-signaling pathway, p53-signalingpathway, insulin-signaling pathway and HIF-1-signaling pathway in the targets of upregulated miRNAs.The downregulated miRNAs were related to extracellular matrix-receptor interaction, protein processingin endoplasmic reticulum, cytokine-cytokine receptor interaction and antigen processing andpresentation. Thus, the identified miRNAs differentially expressed in patients with an improved functionaloutcome that may play a role in the molecular mechanisms that underlie in cardiac repair in patients withischemic cardiac disease. Moreover, these finding indicate that not all autologous cell products may becompetent therapy candidates for cardiac repair These results warrant further investigation to confirmthe effects of the identified differences on the target genes, which could improve the prognosis and unveilnew therapeutic approaches.
CD5-Positive Marginal Zone Lymphoma: Clinical Characteristics of the MSKCC Cohort, and Comparison with the CD5-Negative Population
Authors: Paola Ghione, Kurt S. Bantilan, Erel Joffe, M. Lia Palomba, Ariela Noy, Matthew J Matasar, Philip Caron, Audrey Hamilton, Paul A. Hamlin, Anita Kumar, Colette Owens, Alison J. Moskowitz, Lorenzo Falchi, Gottfried von Keudell, Ildefonso Rodriguez-Rivera, David J. Straus, Steven M. Horwitz, Ahmet Dogan, Andrew D Zelenetz
Journal: Blood (2020)
SAT0722-HPR WHAT IS THE MOST AFFECTED BIOPSYCHOSOCIAL ASPECT IN RHEUMATIC DISEASES?
Authors: Edibe Ünal, Gamze Arin, Derya Gökmen, Sedat Kiraz
Journal: Annals of the Rheumatic Diseases (2019)

<h3>Background:</h3> Rheumatic diseases are chronic illnesses that vary in the extent to different manifestations in musculoskeletal and internal organ systems. In addition to organ involvements, patients with these conditions suffer from biopsychosocial problems such as pain, stiffness, loss of functionality, social isolation, anxiety and depression, fatigue, sleep, and sexuality problems due to the chronic nature of these diseases (1). BETY-BQ is a newly developed biopsychosocial questionnaire that can be used in rheumatic diseases and assesses patients in regards to biopsychosocial status. <h3>Objectives:</h3> The aim of this study was to investigate the most affected biopsychosocial aspect that rheumatic diseases cause to. <h3>Methods:</h3> 343 patients with rheumatic diseases (283 females and 60 males, mean age: 45.95±10.6) who referred to Hacettepe University, Department of Internal Medicine-Rheumatology were included in this study. Biopsychosocial aspects were assessed by using Bilişsel Egzersiz Terapi Yaklaşimi-Biopsychosocial Questionnaire (BETY-BQ)(2). Rasch analysis was used to determine the different biopsychosocial aspects and the most affected one. <h3>Results:</h3> It was found that BETY-BQ has 6 categories assessing pain, functionality &amp; fatigue, emotional status, social participation, sexuality, sleep. When the residual correlation matrix was evaluated, substantial local dependency was observed among the items. Consequently, the sets of items within each of the six subscales were treated as one summary item (testlet) and the data fitted to the Rasch model. Following this, all items were found to fit the model (given a Bonferroni adjustment fit level of 0.0083) (Table 1). Overall, the resulting 6-item item bank was well targeted. The most affected biopsychosocial aspect was found to be 'social participation' and the less affected was 'sleep problems'. <h3>Conclusion:</h3> According to our results, social functioning is the most affected aspect of patients with rheumatic diseases. Following social functioning, sexuality, and emotional status were further affected. This results should be taken into consideration in the multidimensional rehabilitation programs. <h3>References</h3> [1] Van Middendorp H, Evers AW, The role of psychological factors in inflammatory rheumatic diseases: From burden to tailored treatment. Best Pract Res Clin Rheumatol 2016;30(5):932-945. [2] Unal E, Arin G, Karaca NB, et al. Romatizmali hastalar için bir yaşam kalitesi ölçeğinin geliştirilmesi: madde havuzunun oluşturulmasi. J Exerc Rehabil 2017;4(2):67-75. <h3>Disclosure of Interests:</h3> None declared
The Outcomes of Nivolumab Fixed Dose 40 Mg Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
Authors: Liudmila Fedorova, Kirill Lepik, Polina Kotselyabina, Elena Kondakova, Yuri Zalyalov, Evgeniya Borzenkova, Vadim Baykov, Olga S. Epifanovskaya, Elena V. Babenko, Ivan S. Moiseev, Aleksander Kulagin, Natalia Mikhailova, Boris Afanasyev
Journal: Blood (2020)
Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres
Authors: Georgia J McCaughan, Anvita Verma, Silvia Ling, Orly Lavee, John Moore, Adam Bryant
Journal: Blood (2020)
The Crimson 1 Study: A Phase 3 Study to Evaluate the Efficacy and Safety of Subcutaneous Marzeptocog Alfa (activated) for on-Demand Treatment and Control of Bleeding Episodes in Subjects with Hemophilia A or Hemophilia B, with Inhibitors
Authors: Linda Neuman, Shraddha Desai, Tom Knudsen, Frank Del Greco, Howard Levy
Journal: Blood (2020)
Trend in Survival in Patients Undergoing Allogeneic Stem Cell Transplantation: An Institutional Experience
Authors: Justin Jiang, Audrey M. Sigmund, Qiuhong Zhao, Patrick Elder, Don M. Benson, Ashley Rosko, Maria Chaudhry, Naresh Bumma, Abdullah Khan, Srinivas Devarakonda, Sumithira Vasu, Samantha Jaglowski, Basem M. William, Alice S. Mims, Hannah Choe, Karilyn Larkin, Jonathan E. Brammer, Sarah A Wall, Nicole Grieselhuber, Ayman Saad, Sam Penza, Yvonne A. Efebera, Nidhi Sharma
Journal: Blood (2020)